183 related articles for article (PubMed ID: 10075082)
1. Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone.
Manna SK; Gad YP; Mukhopadhyay A; Aggarwal BB
Biochem Pharmacol; 1999 Apr; 57(7):763-74. PubMed ID: 10075082
[TBL] [Abstract][Full Text] [Related]
2. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
3. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 Jun; 164(11):5815-25. PubMed ID: 10820260
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
Manna SK; Mukhopadhyay A; Aggarwal BB
J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
[TBL] [Abstract][Full Text] [Related]
5. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Aggarwal BB
J Immunol; 2000 Nov; 165(10):5962-9. PubMed ID: 11067959
[TBL] [Abstract][Full Text] [Related]
7. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
Natarajan K; Manna SK; Chaturvedi MM; Aggarwal BB
Arch Biochem Biophys; 1998 Apr; 352(1):59-70. PubMed ID: 9521814
[TBL] [Abstract][Full Text] [Related]
9. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors.
Shrivastava A; Manna SK; Ray R; Aggarwal BB
J Virol; 1998 Dec; 72(12):9722-8. PubMed ID: 9811706
[TBL] [Abstract][Full Text] [Related]
11. Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappaB, activation protein-1, and c-Jun N-terminal kinase.
Manna SK; Haridas V; Aggarwal BB
J Interferon Cytokine Res; 2000 Aug; 20(8):725-35. PubMed ID: 10954916
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis.
Manna SK; Sah NK; Aggarwal BB
J Biol Chem; 2000 May; 275(18):13297-306. PubMed ID: 10788436
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1.
Manna SK; Kuo MT; Aggarwal BB
Oncogene; 1999 Jul; 18(30):4371-82. PubMed ID: 10439045
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression.
Manna SK; Aggarwal BB
J Immunol; 1999 Feb; 162(4):2095-102. PubMed ID: 9973483
[TBL] [Abstract][Full Text] [Related]
15. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.
Ashikawa K; Majumdar S; Banerjee S; Bharti AC; Shishodia S; Aggarwal BB
J Immunol; 2002 Dec; 169(11):6490-7. PubMed ID: 12444159
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester.
Majumdar S; Lamothe B; Aggarwal BB
J Immunol; 2002 Mar; 168(6):2644-51. PubMed ID: 11884428
[TBL] [Abstract][Full Text] [Related]
18. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
Takada Y; Singh S; Aggarwal BB
J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
[TBL] [Abstract][Full Text] [Related]
19. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation.
Alpert D; Schwenger P; Han J; Vilcek J
J Biol Chem; 1999 Aug; 274(32):22176-83. PubMed ID: 10428782
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
